StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)
StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Up 6.0 % NASDAQ:AKTX opened at $3.16 on Monday. The company has a 50-day moving average of $3.56 and a 200-day moving […]
More Stories
Larson Financial Group LLC Boosts Holdings in Eaton Vance Enhanced Equity Income Fund II (NYSEARCA:EOS)
Larson Financial Group LLC boosted its position in Eaton Vance Enhanced Equity Income Fund II (NYSEARCA:EOS – Free Report) by...
Larson Financial Group LLC Acquires 3,957 Shares of iShares Core Dividend ETF (BATS:DIVB)
Larson Financial Group LLC lifted its holdings in shares of iShares Core Dividend ETF (BATS:DIVB – Free Report) by 17.4%...
Dwayne Frederick Giggs Sells 2,000 Shares of Canadian Natural Resources Limited (TSE:CNQ) Stock
Canadian Natural Resources Limited (TSE:CNQ – Get Free Report) (NYSE:CNQ) Senior Officer Dwayne Frederick Giggs sold 2,000 shares of the...
Insider Selling: Liberty Live Group (NASDAQ:LLYVA) CAO Sells 1,094 Shares of Stock
Liberty Live Group (NASDAQ:LLYVA – Get Free Report) CAO Brian J. Wendling sold 1,094 shares of the business’s stock in...
Brokerages Set The AES Co. (NYSE:AES) Price Target at $22.38
The AES Co. (NYSE:AES – Get Free Report) has earned an average rating of “Moderate Buy” from the ten brokerages...
Sompo Asset Management Co. Ltd. Sells 510 Shares of Aptiv PLC (NYSE:APTV)
Sompo Asset Management Co. Ltd. lowered its position in shares of Aptiv PLC (NYSE:APTV – Free Report) by 8.6% during...